title: Chemotherapy for advanced non-small cell lung cancer.
abstract: Lung cancer is the most lethal cancer in both men and women. Given that chemotherapy for advanced disease is marginally beneficial and noncurative, its use must be governed judiciously, with each decision being evaluated individually for each patient. Chemotherapy for lung cancer has progressed over the past decade, and with the advent of new agents, its future looks promising.
authors.affiliation: Department of Medical Oncology/STAMP, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
authors.forename: R S
authors.initials: RS
authors.lastname: Herbst
authors.forename: N H
authors.initials: NH
authors.lastname: Dang
authors.forename: A T
authors.initials: AT
authors.lastname: Skarin
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008297:Male; D011379:Prognosis; D011788:Quality of Life
chemical_list: D000970:Antineoplastic Agents